IT201900024997A1 - Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie - Google Patents

Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie

Info

Publication number
IT201900024997A1
IT201900024997A1 IT102019000024997A IT201900024997A IT201900024997A1 IT 201900024997 A1 IT201900024997 A1 IT 201900024997A1 IT 102019000024997 A IT102019000024997 A IT 102019000024997A IT 201900024997 A IT201900024997 A IT 201900024997A IT 201900024997 A1 IT201900024997 A1 IT 201900024997A1
Authority
IT
Italy
Prior art keywords
flu
association
prevention
states
treatment
Prior art date
Application number
IT102019000024997A
Other languages
English (en)
Inventor
Maio Umberto Di
Original Assignee
Dymalife Res S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dymalife Res S R L filed Critical Dymalife Res S R L
Priority to IT102019000024997A priority Critical patent/IT201900024997A1/it
Publication of IT201900024997A1 publication Critical patent/IT201900024997A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
IT102019000024997A 2019-12-20 2019-12-20 Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie IT201900024997A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102019000024997A IT201900024997A1 (it) 2019-12-20 2019-12-20 Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000024997A IT201900024997A1 (it) 2019-12-20 2019-12-20 Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie

Publications (1)

Publication Number Publication Date
IT201900024997A1 true IT201900024997A1 (it) 2021-06-20

Family

ID=70228518

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000024997A IT201900024997A1 (it) 2019-12-20 2019-12-20 Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie

Country Status (1)

Country Link
IT (1) IT201900024997A1 (it)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012049045A1 (en) * 2010-10-11 2012-04-19 Indena S.P.A. Formulations for the treatment of disorders of the upper respiratory tract

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012049045A1 (en) * 2010-10-11 2012-04-19 Indena S.P.A. Formulations for the treatment of disorders of the upper respiratory tract

Non-Patent Citations (34)

* Cited by examiner, † Cited by third party
Title
"Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD", THORAX, vol. 58, no. 11, November 2003 (2003-11-01), pages 942 - 6
ALTINYAY, Q.ERGENE OZ, B.ALTUN, M. L.: "Quantity of shikimic acid in the methanolic extracts of three Alnus taxons growing in Turkey", TURK. J. PHARM. SKIING, 2016
ANONYMOUS: "Antimicrobial treatment guide lines for acute bacterial rhinosinusitis", OTOLARYNGOLOGY - HEAD & NECK SURGERY, vol. 130, 2004, pages 1 - 45
BEGOÑA EUBA ET AL: "Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae", SCIENTIFIC REPORTS, vol. 7, no. 1, 16 October 2017 (2017-10-16), XP055715246, DOI: 10.1038/s41598-017-13034-7 *
BROOK I.: "Bacteriology of Acute and Chronic frontal sinusitis", ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, vol. 128, 2002, pages 583 - 5
CHAO-JEN LIN ET AL: "Polygonum cuspidatum and Its Active Components Inhibit Replication of the Influenza Virus through Toll-Like Receptor 9-Induced Interferon Beta Expression", PLOS ONE, vol. 10, no. 2, 6 February 2015 (2015-02-06), pages e0117602, XP055715247, DOI: 10.1371/journal.pone.0117602 *
CHERRY JDSHAPIRO NLDEVILLE JG: "Textbook of infectious diseases", 2004, SAUNDERS, article "Sinusitis", pages: 201 - 212
DATABASE GNPD [online] MINTEL; 19 November 2019 (2019-11-19), ANONYMOUS: "Free Breath Syrup", XP055715123, retrieved from www.gnpd.com Database accession no. 7039995 *
DAVID SHOLTO ET AL: "Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis", COMPLEMENTARY THERAPIES IN MEDICINE, vol. 44, 19 March 2019 (2019-03-19), pages 18 - 26, XP085694377, ISSN: 0965-2299, DOI: 10.1016/J.CTIM.2019.03.011 *
DG. SOARESAC. ANDREAZZAM. SALVADOR: "Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems", J AGRIC FOOD CHEM, vol. 51, no. 4, February 2003 (2003-02-01), pages 1077 - 80
DZS. LIQY. MACA. WANG: "effect of resveratrol on pancreatic oxygen free radicals in rats with severe acute pancreatitis", WORLD J GASTROENTEROL, vol. 12, no. 1, January 2006 (2006-01-01), pages 137 - 40
FOKKENS WJLUND VJMULLOL J ET AL.: "Europan position paperon rhinosinusitis and nasal polyps 2012", RHINOL, vol. 23, 2012, pages 3
G. ZHANGCR. FLACHR. MENDELSOHN: "Tracking the depression of resveratrol triphosphate in skin by confocal Raman microscopic", J CONTROL RELEASE, vol. 123, no. 2, November 2007 (2007-11-01), pages 141 - 7
GELARDI MFIORELLA MLLEO G ET AL.: "Cytology in the diagnosis of rhinosinusitis", PEDIATR ALLERGY IMMUNOL, vol. 18, 2007, pages 50 - 52
HEIKKINEN TJARVINEN A: "The commoncold.", LANCET, vol. 361, 2003, pages 51 - 9
HEIKKINEN TRUUSKANEN O: "Temporal development of acute otitim media during upper respiratoy tract infection", PEDIATR INFECT DIS J, vol. 13, 1994, pages 659 - 661
J. MARTINEZJJ. MORENO: "effect of resveratrol, a natural polyphenol compound, on reactive oxygen species and prostaglandin production", BIOCHEM PHARMACOL, vol. 59, no. 7, April 2000 (2000-04-01), pages 865 - 70
K. SUBBARAMAIAHFR MICHALUARTWJ. CHUNGT. TANABEN. TELANGAJ. DANNENBERG: "Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells", ANN N Y ACAD SCI, vol. 889, 1999, pages 214 - 23
KOIBUNEN PKONTIOKARI TNIEMELA M ET AL.: "Time to development of acute otitis media during an upper respiratory tract infection in children", PEDIATR INFECT DIS J, vol. 18, 1999, pages 303 - 305
L. GOJKOVIC-BUKARICAA. NOVAKOVICV. KANJUHM. BUMBASNIEVICA. LESICH. HEINLE: "A role of ion channels in the endothelium-independant relaxation of rat mesenteric artery induced by resveratrol.", J PHARMACOL SCI, vol. 108, no. 1, September 2008 (2008-09-01), pages 124 - 30
LUDWICZUK, A.SAHA, A.KUZUHARA, T.ASAKAWA, Y.: "Bioactivity guided isolation of anticancer constituents from leaves of Alnus sieboldiana (Betulaceae", PHYTOMEDICINE, vol. 18, 2011, pages 491 - 498
M. KAMIYAMAY. KISHIMOTOM. TANIK. ANDOHK. UTSUNOMIYAK. KONDO: "inhibition of low- density lipoprotein oxidation by Nagano purple grain (Vitis viniferaxVitislabrusca", J NUTR SCI VITAMINOL, vol. 55, no. 6, December 2009 (2009-12-01), pages 471 - 8
MELTZER EO, HAMILOS DL, HADLEY JA: "Rhinosinusitis: Establishment definitions for clinical research and patient care.", THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 114, 2004, pages 155 - 212, XP004695730, DOI: 10.1016/j.jaci.2004.09.029
MIDDLETON P ET AL: "Antioxidant, Antibacterial Activities and General Toxicity of Alnus glutinosa, Fraxinus excelsior and Papaver rhoeas", IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, XX, IR, vol. 2, 1 January 2005 (2005-01-01), pages 81 - 86, XP002660953, ISSN: 1796-6866 *
MIDDLETON, P.STEWART, F.AL-QAHTANI, S.EGAN, P.O'ROURKE, C.ABDULRAHMAN, A.BYRES, M.MIDDLETON, M.KUMARASAMY, Y.SHOEB, M.: "Antioxidant, antibacterial activities and general toxicity of Alnus glutinosa, Fraxinus excelsior and Papaver rhoeas", IRAN. J. PHARM. RES., vol. 2, 2005, pages 81 - 86, XP002660953
MIRIKOVA, I.VAVERKOVA, S.: "Echinacea-chemical composition, immunostimulatory activities and uses", THAISZIA JOUMAL OF BOTANY, vol. 16, 2006, pages 11 - 26
NC. YANGCH. LEETY. SONG: "Evaluation of Resveratrol oxidation in vitro and the cruciai role of bicarbonate ions", BIOSCI BIOTECHNOL BIOCHEM, vol. 74, no. 1, 2010, pages 63 - 8
PAYNE SCBENNINGER MS: "Staphylococcus aureus is a major pathogen in acute bacterial rhinosinusitis: A metaanalysis", CLINICAL INFECTIOUS DISEASES: AN OFFICIAL PUBLICATION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA, vol. 45, 2007, pages 121 - 127
REVAI KDOBBS LANAIR S ET AL.: "Incidence of acute otitis media and sinusitis complication upper respiratory tract infection: the effect of age", PEDIATRICS, vol. 119, 2007, pages 1408 - 12
S. PERVAIZ: "Resveratrol: From grapevines to mammary biology.", FASEB J, vol. 17, no. 14, November 2003 (2003-11-01), pages 1975 - 85
SATI, S. C.SATI, N.SATI, O. P.: "Bioactive constituents and medicinal importance of genus Alnus", PHARMACOGN. REV., vol. 5, 2011, pages 174 - 183
TUNG, NO. H.RA, J. C.SOHN, D. H.KIM, Y. H.: "A new diarylheptanoid from the bark of Alnus japonica", J. ASIAN PAT. RES PROD., vol. 12, 2010, pages 921 - 924
VIMALANATHAN, S.KANG, L.AMIGUET, V. T.LIVESEY, J.ARNASON, J. T.HUDSON, J.: "Echinacea purpurea. Aerial parts contain multiple antiviral compounds", PHARMACEUTICAL BIOLOGY, vol. 43, no. 9, 2005, pages 740 - 745, XP009133242, DOI: 10.1080/13880200500406354
YH. HSIEHSS. HUANGFC. WEILM. HUNG: "Resveratrol attenuates ischemia - reperfusion- induced leukocyte - endothelial celi adihexive interactions and prolongs allograft survival across the MHC barrier", CIRC J, vol. 71, no. 3, March 2007 (2007-03-01), pages 423 - 8

Similar Documents

Publication Publication Date Title
MA43108A (fr) Anticorps neutralisant le virus syncytial respiratoire humain
NZ625373A (en) Improvements relating to nasal dilation devices
BR112012016094A2 (pt) respirador com peça facial filtrante tendo uma malha auxética no corpo da máscara
MA46621A (fr) Traitements combinés comprenant l'administration d'imidazopyrazinones
DK3054912T3 (da) Fremgangsmåde og anordning til lindring af en persons stressrelaterede søvnforstyrrelse og reduktion af personens stressniveau
MA40920A (fr) Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
MA44232A (fr) Dispositif de respiration
MA43049A (fr) Anticorps de liaison à un récepteur cannabinoïde 1 humain (cb1)
MA43758A (fr) Procédés pour déterminer le dosage d'un agent thérapeutique et traitements associés
IT201700109080A1 (it) Composizione per la prevenzione e/o il trattamento delle affezioni delle vie respiratorie
MA49443A (fr) Dispositif d'inhalation à buse multi-liquide
FR3026000B3 (fr) Dispositif applicateur pour le massage et l'application d'un cosmetique sur le corps humain
IT201900024997A1 (it) Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie
PT3937949T (pt) Fitoecdisonas e seus derivados para utilização no tratamento da alteração da função respiratória
FR3001155B1 (fr) Appareil d'assistance respiratoire avec turbine insonorisee
MA43782A (fr) Dispositif d'inhalation d'aérosol
DE102020133399A8 (de) Filter und Atemschutzmaske
ES1249295Y (es) Mascarilla higiénica buco-nasal
MA46975A (fr) Structure de respiration de véhicule et son ensemble
IT201900022359A1 (it) Dispositivo per la verifica e il controllo delle arcate dentarie
ES1279819Y (es) Dispositivo asegurador descensor
IT201700056855A1 (it) Dispositivo per il lavaggio di una persona allettata o di una ferita
IT201700060851U1 (it) Composizione comprendente fitosteroli e/o fitostanoli per il trattamento delle rughe e dell'invecchiamento cutaneo.
EP3806686A4 (en) DENTAL CANNABIS DELIVERY DEVICE AND USE
ES1254578Y (es) Respirador